Docemy
Docemy is an Indian EdTech platform preparing medical students for NEET PG, INICET, NEXT, and Final Year MBBS exams via pattern-based high-yield notes, a clinical QBank, mock test series, and an AI tutor, sold through self-serve website and mobile-app subscriptions.
- Company typePrivate
- Founded2020
- HeadquartersKochi, India
- Headcount11–50
- GTM typeB2C
- OfferingSoftware
What Docemy does
Docemy is a Kochi, India-based EdTech platform founded in 2020 that prepares Indian medical students for high-stakes postgraduate entrance examinations. Its core offering, branded "High Strike Prep," combines 900+ pages of printed high-yield notes across 19 subjects, a question bank of previous-year questions (PYQs) with multi-layered explanations, and a mock test series, all structured around a pattern-analysis methodology derived from years of NEET PG and INICET papers. The platform claims a NEET PG 2025 strike rate of 163/200 questions covered and reports a 4.9/5 average rating with a 95% pass rate on its Final Year Program.
Under the hood, Docemy layers an AI tutor ("My NEET PG Tutor") that adapts to individual learning style via page-by-page teaching and quick quizzes, alongside a Studyathon community feature for live study sessions and peer accountability. Content and product surface span NEET PG, INICET, and NEXT for PG aspirants, and a separate Final Year MBBS Program covering 10 clinical subjects with 300+ hours of recorded video lectures. Customers access the platform via a self-serve website (docemy.com, prep.docemy.com) and a mobile app with offline video downloads, with WhatsApp-API counsellor support integrated into the purchase funnel.
The business model is subscription-based, direct-to-consumer, and India-only. Tiered bundles are priced in INR (₹2,999 to ₹11,999 for NEET PG bundles, ₹3,499 to ₹9,999 for Final Year tiers), with coupons (NEETPG2026, FINALYEAR) actively used. Docemy appears to be a privately held, bootstrapped company with 11-50 employees and 19+ credentialed medical faculty across specialties, generating no disclosed revenue or funding data.
Docemy firmographics
Firmographics- Name
- Docemy
- Legal name
- Docemy
- Website
- https://docemy.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Docemy is an Indian EdTech platform preparing medical students for NEET PG, INICET, NEXT, and Final Year MBBS exams via pattern-based high-yield notes, a clinical QBank, mock test series, and an AI tutor, sold through self-serve website and mobile-app subscriptions.
- Ownership category
- akta.pro rank
Docemy industry classification
Industry- Product category
- Medical exam preparation / EdTech
- NAICS
- Exam Preparation and Tutoring (611691)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Exam Prep & Standards-Aligned Review Courseware (Within Curriculum) (EDAFACAO)
- akta.pro secondary industry
- Test Item Banks, Question Authoring & Assessment Design Tools (EDAFADAC)
Keywords
Where Docemy is headquartered
LocationHeadquarters
- HQ city
- Kochi
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Docemy business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- NEET PG/INICET High Strike Prep Subscriptions: Subscription-based access to Notes, QBank, and Test Series packages with varying validity periods (3-12 months). Three bundle tiers with tiered pricing from ₹2,999 to ₹11,999.
- Final Year MBBS Program Subscriptions: Subscription-based access to video lectures, notes, QBank, and structured study plans for Final MBBS students. Plans range from ₹3,499 (3 months) to ₹9,999 (12 months) with 95% pass rate guarantee messaging.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Bundle 1 - Notes Only |
| Subscription | Multi-year contract | Bundle 2 - QBank + Test Series |
| Subscription | Multi-year contract | Bundle 3 - Complete Package (Notes + QBank + Test Series) |
| Subscription | Multi-year contract | Final Year Program - 3 Months |
| Subscription | Multi-year contract | Final Year Program - 6 Months |
| Subscription | Multi-year contract | Final Year Program - 12 Months |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Docemy product offering
Product offeringCore offering
Docemy operates a direct-to-consumer online platform that prepares Indian medical students for NEET PG, INICET, NEXT, and Final MBBS exams through printed high-strike notes, a previous-year-question bank with detailed explanations, simulated test series, and an AI tutor. Its flagship "High Strike Prep" bundle combines these elements with tiered subscription pricing, while the Final Year MBBS Program delivers 300+ hours of subject-wise video lectures, digital notes, and structured study plans.
Product overview
Docemy is an online medical education platform offering a unified product ecosystem for MBBS students preparing for NEET PG, INICET, and Final MBBS exams. The core offering is the High Strike Prep system, which combines High Strike Notes (printed 900+ page book covering 19 subjects), Core QBank + PYQs (thousands of previous year questions with detailed explanations), and Test Series (mock tests). The platform also features My NEET PG Tutor, an AI-powered personalized learning companion that adapts to individual learning styles. A separate Final Year Program targets MBBS students with 300+ hours of video lectures, digital notes, QBank, and performance tracking for 10 clinical subjects. All offerings are accessible via web and mobile app, with downloadable content for offline study.
Differentiator
Problem solved
Functional benefit
Products and services
- High Strike Prep
- High Strike Notes
- Core QBank + PYQs
- Test Series
- Final Year Program
- NEET PG / NEXT Videos, QBank, Test Series & Rapid Revision
Quantifiable outcome
- 163/200 questions covered in NEET PG 2025 from high-strike material
- +4 more outcomes
Companies that use Docemy
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
Docemy technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability3 records
Feature4 records
Docemy partnerships and signals
Strategic signalScale indicators8 records
Recent moves6 records
Expansion highlights6 records
Docemy competitors and assessment
Company assessmentDirect peers
- eMedicoz: eMedicoz is an Indian medical exam prep platform offering video lectures, MCQ banks, and test series for NEET PG and FMGE aspirants, with a similar subscription-driven model targeting postgraduate medical entrance candidates.
- Prepladder: Prepladder is a major NEET PG and INI-CET preparation platform with faculty-led video content, QBank, and test series, targeting the same Indian medical postgraduate aspirant segment as Docemy with a comparable subscription model.
- Doctutorials: Doctutorials (previously Doctutorial) is an India-focused NEET PG prep platform offering video lectures, notes, and QBank content with subscription-based access, serving the same aspirant segment with comparable content formats.
- Marrow: Marrow (by DBMCI) is a leading Indian medical exam prep platform offering video lectures, question banks, and test series for NEET PG and INICET aspirants, directly competing with Docemy in the same target market with similar subscription-based content delivery.
- Cerebellum Academy: Cerebellum Academy provides NEET PG, INI-CET, and FMGE preparation through live classes, recorded lectures, and test series, directly competing with Docemy for Indian postgraduate medical aspirants.
- DAMS (Delhi Academy of Medical Sciences): DAMS is one of India's longest-running medical coaching institutes offering live and recorded courses, test series, and QBank products for NEET PG and INICET preparation, serving the same aspirant base as Docemy.
Regional players
- SelfStudy365: SelfStudy365 is an Indian EdTech platform offering medical exam preparation content including NEET PG test series and video lectures, primarily serving the Indian market with comparable subscription-based content.
Broad incumbents
- Unacademy: Unacademy is a large Indian EdTech incumbent with a dedicated NEET PG vertical featuring multiple faculty members, test series, and subscription products, offering overlapping capabilities across a wider K-12 and competitive exam portfolio.
- BYJU'S Exam Prep: BYJU'S Exam Prep (formerly Aakash Digital) covers NEET PG preparation as part of a much broader medical and engineering exam portfolio, competing with Docemy on subscription-based prep content but across a much wider range of verticals.
Emerging players
- Merilogy: Merilogy is an emerging India-based medical learning platform focused on MBBS curriculum and PG entrance preparation, with partial overlap to Docemy's content offering but a narrower current footprint.
Market position
Strengths3 records
Weaknesses5 records
Competitive moat5 records
Key highlights6 records
Customer concentration
Docemy social profiles
Digital presenceDocemy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Docemy leadership team
Management profileNumber of profiles
Profiles1 record
Docemy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Docemy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Docemy
What does Docemy do?
Docemy operates a direct-to-consumer online platform that prepares Indian medical students for NEET PG, INICET, NEXT, and Final MBBS exams through printed high-strike notes, a previous-year-question bank with detailed explanations, simulated test series, and an AI tutor. Its flagship "High Strike Prep" bundle combines these elements with tiered subscription pricing, while the Final Year MBBS Program delivers 300+ hours of subject-wise video lectures, digital notes, and structured study plans.
Is Docemy a public or private company?
Docemy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Docemy founded?
Docemy was founded in 2020. It employs 11 to 50 people.
Where is Docemy based?
Docemy is headquartered in Kochi, India, in the Asia region.
How does Docemy make money?
Two revenue lines are on record. NEET PG/INICET High Strike Prep Subscriptions are the primary driver. The others are final Year MBBS Program Subscriptions.
Who are Docemy's main competitors?
Direct peers on record are eMedicoz, Prepladder, Doctutorials, Marrow, Cerebellum Academy and DAMS (Delhi Academy of Medical Sciences). SelfStudy365 is listed as a regional player. Broad incumbents are Unacademy and BYJU'S Exam Prep. Merilogy is listed as an emerging player.
Does Docemy have an API?
No public API is recorded for Docemy.
What industry is Docemy in?
Docemy's product category is Medical exam preparation / EdTech. Its primary akta.pro industry code is EDAFACAO, Exam Prep & Standards-Aligned Review Courseware (Within Curriculum), with a secondary code of EDAFADAC, Test Item Banks, Question Authoring & Assessment Design Tools. Its NAICS code is 611691 and its SIC code is 7372.